In developed communities, particularly in the US, Vegans have earned unfortunate reputations for being a little annoying. However, new scientific research suggests that they may actually have the right standpoint on the issue of meat consumption, especially for anyone who is interested in actually helping the environment. According to a recent study, going meatless is one of the best ways to save the world.
The study in question is the joint effort by Global Food Security Programme of the UK and the Seventh Framework Programme of the EU, Futurism reports. The study basically looked at what would happen if people stopped eating livestock meats and swapped them for anything else. In this case, insects were the replacements.
Without getting too lost in the idea of munching on creepy-crawlies, which have been proven to not only be nutritious but also delicious, the results of the research were pretty conclusive. Basically, if people really want to save the environment and, by extension humanity, meat consumption is going to have to drop considerably.
In the paper that the researchers published, it would seem that the meat issue isn’t the only thing at stake here, either. Since more resources come from livestock such as eggs and dairy products, drastically reducing the practice would lead to a shortage in those areas, as well.
“Animal products, i.e. meat, milk and eggs, provide an important component in global diets, but livestock dominate agricultural land use by area and are a major source of greenhouse gases,” the paper reads. “Cultural and personal associations with animal product consumption create barriers to moderating consumption, and hence reduced environmental impacts.”
This concept isn’t new, by any means. Some experts have even posited a few years ago that giving up on eating beef would have a much larger impact in the fight against climate change than giving up cars. That’s just the cows. Giving up on chickens, pork, sheep, goats, and turkey would make the effects exponentially more noticeable.


Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Neuralink Expands Brain Implant Trials with 12 Global Patients
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 



